[Hepatitis C virus infection and hemodialysis: update 2014].
Since hepatitis C virus (HCV) infection is much common among hemodialysis (HD) patients, the natural history of HCV is not sufficiently understood. It has been reported that HCV infection is one of the major risk factors for the lower survival among HD patients. Recent progression of the therapy involving direct acting antiviral (DAA) can eliminate HCV infection in almost HCV infected patients, resulting HD patients should also get this benefit. Though HD patients have many restricted factors for accepting anti HCV therapy, the significance of clinical usefulness of interferon beta that has less adverse effect should be more deeply considered with newly developed DAAs for eliminating HCV infected HD patients.